Caption Management’s Capricor Therapeutics CAPR Stock Holding History

Caption Management’s Portfolio CAPR Stock Details CAPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.46M	Sell	146,800 -77,000	-34%	-$2.05M	0.03%	562
2025 Q4	$6.46M	Sell	223,800 -223,700	-50%	-$2.92M	0.04%	438
2025 Q3	$3.23M	Sell	447,500 -29,900	-6%	-$220K	0.03%	652
2025 Q2	$4.74M	Buy	477,400 +327,400	+218%	+$3.46M	0.05%	421
2025 Q1	$1.42M	Sell	150,000 -426,300	-74%	-$5.92M	0.01%	798
2024 Q4	$7.95M	Hold	576,300	–	–	0.08%	245
2024 Q3	$8.77M	Buy	576,300 +270,600	+89%	+$1.34M	0.14%	176
2024 Q2	$1.46M	Buy	+305,700	New	+$1.7M	0.02%	557

Other funds holding CAPR

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JHC

Jones Hill Capital New York $466M AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Caption Management's CAPR Position: Q2 2025 in Review

Caption Management sold out of Capricor Therapeutics (CAPR) in Q2 2025, closing a stake of 140,000 shares — an estimated $1.48M sold.

Caption Management first reported a position in CAPR in Q1 2025 and held it in 1 quarter. The position peaked at $1.33M in Q1 2025. 107 funds tracked by Wall St. Rank hold CAPR as of Q2 2025.

Caption Management reported no remaining Capricor Therapeutics position as of Q2 2025 after selling out during the quarter.
Caption Management sold 140,000 Capricor Therapeutics shares in Q2 2025, an estimated $1.48M.
Caption Management first reported a position in Capricor Therapeutics in Q1 2025 and held it in 1 quarter.
Caption Management's Capricor Therapeutics position peaked at $1.33M in Q1 2025.
107 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2025.

Based on Caption Management's 13F filing for Q2 2025, filed 14 Aug 2025.